openPR Logo

Press Releases from XtalPi (8 total)

The New Infrastructure of Medicine: A Digital, Automated, and AI-Driven Chemistr …

In an era where biopharma R&D faces unprecedented pressure-soaring costs, shrinking product lifecycles, and a mere 4.1% IRR for top pharma companies-the need for transformative

How Integrated Autonomous Lab Platforms Are Transforming Scientific Research

The modern research and development landscape is undergoing a significant transformation. For decades, scientific discovery in the life sciences and materials industries has relied heavily

Accelerating Drug Discovery: Leveraging XtalPi's Intelligent Software for Faster …

The pharmaceutical industry is currently undergoing a paradigm shift as the traditional, labor-intensive models of drug development are being replaced by data-driven, automated ecosystems. This

What Defines an Expert Polymorph Screening Service? A Look Inside XtalPi's Scien …

Summary: The pharmaceutical industry's traditional approach to polymorph screening is increasingly challenged by late-appearing polymorph risks, escalating molecular complexity, and stringent regulatory demands. XtalPi's AI-driven

Advanced Crystal Structure Prediction Platform: Essential Selection Guide for Ma …

Executive Summary: Selecting the right crystal form is crucial for the performance and stability of pharmaceuticals and advanced materials. Traditional experimental screening is slow, costly,

Beyond Serendipity: Redefining Rational Molecular Glue Discovery via AI-driven M …

Beyond Serendipity: Redefining Rational Molecular Glue Discovery via AI-driven methodologies (en.xtalpi.com) As a new generation of proximity-induced therapeutics, molecular glues represent a unique class of small

Accelerating Drug Discovery with AI and Next-Generation Automation

Accelerating Drug Discovery with AI and Next-Generation Automation The pharmaceutical industry is currently witnessing a transformative shift as the traditional, trial-and-error approach to drug development gives

XtalPi: Defining the Next-Generation R&D Paradigm Through AI for Science

The methods that drive scientific discovery are undergoing a quiet but substantial transformation. Empirical, iterative experimentation has driven extraordinary progress across biopharma, advanced materials, and

Go To Page: